XRF-Guided Biopsy - A Transformative Modality in Prostate Cancer
ProSight is a medical device startup spun out of the Weizmann Institute of Science, developing a real-time ex-vivo biopsy samples scanner, potentially transforming prostate cancer diagnosis based on new, never-used-before biomarkers, addressing the limitations in all biopsy procedures. Need: Current methods in prostate cancer biopsy often miss tumors and le…